A new continuous glucose monitor (CGM) that is not only non-invasive but that predicts blood sugar levels from ECG data ...
Not everyone in the health field is so bullish on the prospects of CGMs for everyone, and question whether digging in too ...
Abbott Laboratories slightly lifted its annual profit forecast on Wednesday, after beating Wall Street estimates for ...
Continuous glucose monitors (CGM), once exclusive to diabetics, are now available over-the-counter, opening new possibilities ...
Continuous Glucose Monitoring Devices Market to reach a value of US$ 12.51 Bn by 2031 at a CAGR of 9.9% between 2024 and 2031 BURLINGAME, CA, UNITED STATES, October 15, 2024 /EINPresswire / -- A ...
The medical devices industry is on the verge of an incoming boom, fueled by its growing demand and technological advancements ...
Abbott's recent results show 7.6% organic revenue growth, driven by medical devices and pharmaceuticals. Click here to read ...
The CEO at the Illinois-based company with operations in Minnesota expects earning to return to a pre-pandemic profit model ...
Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for ...
More and more people are talking abut the monitoring device, also known as CGM, for non-diabetics. But not everyone in the health field is so bullish on the prospects of CGMs for everyone ...